chitosan has been researched along with Malignant Melanoma in 49 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (8.16) | 29.6817 |
| 2010's | 19 (38.78) | 24.3611 |
| 2020's | 26 (53.06) | 2.80 |
| Authors | Studies |
|---|---|
| Behbood, L; Ebrahimi, S; Jalilian, F; Janfaza, S; Limoee, M; Pourmanouchehri, Z; Vosoughi, A | 1 |
| Bazylińska, U; Caltagirone, C; Fornasier, M; Handschin, S; Kulbacka, J; Manni, LS; Mezzenga, R; Murgia, S; Picci, G; Wawrzyńczyk, D | 1 |
| Abdi, F; Arkan, E; Eidizadeh, M; Gamizgy, YH; Mansouri, K; Naseriyeh, T; Valipour, E | 1 |
| Bai, Y; Fang, X; Fu, B; Huang, H; Li, X; Ma, C; Meng, Z; Miao, W; Qian, C; Ren, H; Tao, X; Wang, A; Yang, Z | 1 |
| Guo, J; Kong, S; Li, W; Liao, M; Lv, L; Sun, H; Yang, X; Zhang, S; Zhao, T | 1 |
| Azambuja, JH; Braganhol, E; de Cássia Sant'ana, R; de Souza, PO; Debom, GN; Fachel, FNS; Gelsleichter, NE; Lenz, GS; Michels, LR; Roliano, GG; Teixeira, FC; Teixeira, HF; Visioli, F | 1 |
| Antonova, E; Avvakumova, N; Fadeeva, I; Gorshenin, D; Hambikova, A; Kashutina, M; Mitrokhin, O; Shcherbakov, D; Sidorova, E; Sukhov, V; Vysochanskaya, S; Zhdanova, A; Zhernov, Y | 1 |
| Ataabadi, FV; Etebari, M; Oveissi, F; Taheri, A | 1 |
| Cao, Z; Chao, T; Liu, Z; Peng, R; Ren, J; Wei, T; Wu, Y; Zhuang, Q | 1 |
| Chang, R; Guan, F; He, Y; Liu, K; Yao, M; Zhang, C; Zhao, D | 1 |
| Ghanbariasad, A; Hosseini, H; Karimivaselabadi, A; Osanloo, M; Zarenezhad, E | 1 |
| Iyer, AK; Jain, S; Kashaw, SK; Kushwah, V; Sahu, P; Sau, S | 1 |
| Shen, J; Xie, L; Yang, Y | 1 |
| Bai, X; Chen, M; Liu, H; Lu, C; Pan, X; Qin, W; Quan, G; Wang, L; Wu, C; Yang, P | 1 |
| Acuña-Castillo, C; Barrera-Avalos, C; Escobar, A; Fernandez, R; Huidobro-Toro, JP; Imarai, M; Kogan, MJ; Matiacevich, S; Milla, LA; Pavez, J; Robles-Planells, C; Rojo, LE; Salas-Huenuleo, E; Sánchez-Guerrero, G; Spencer, E | 1 |
| Batista, RK; Facchini, JC; Lionzo, MIZ; Paim, TC; Vedovatto, S; Wink, MR | 1 |
| Kumar, P; Musalli, AH; Roy, P; Talukdar, PD; Wong, TW | 1 |
| Acevedo-Mackey, D; Acharjee, N; Akhtar, K; Al-Buriahi, MS; Amandi, A; An, Y; Anjum, NA; Asgari, Q; Badiei, B; Baez Vasquez, AY; Bagley, GD; Bahreini, MS; Bajelan, S; Baluja, MQ; Barbieri, MA; Batalha, MA; Bettiol, H; Bhattarai, U; Biset, JC; Bjerg, M; Björnsson, BT; Boag, AM; Borthwick, MS; Boukhris, I; Bragança, MLBM; Breves, JP; Britz-McKibbin, P; Broaddus, RR; Burnell, JE; Camargo, CA; Campo, M; Carlsen, KL; Catchpole, B; Cavalli, L; Chai, C; Chanakya, HN; Chang, AYH; Chantada, A; Chen, W; Chen, X; Chen, Y; Cheng, ZL; Chenoweth, DA; Chhetri, S; Coelho, CCNDS; Coker, ES; Cole, MA; Coniglio, A; Connor, TR; Corbishley, A; D'Arienzo, M; da Silva, AAM; Dai, Y; de Oliveira, BR; Dignac, MF; Dong, A; Dottino, JA; Duo, J; Einarsdottir, IE; Ekanayake, EMDNK; El Fels, L; El Hayany, B; El Shahawy, O; Elliott, RJR; Fabrizi, E; Farkas, K; Fellman, B; Fenoglio, D; Ferrario, M; Flögel, F; Fujiogi, M; Gamage, BD; Ganson, KT; Gao, X; Gärtner, S; Gautam, A; Gautam, S; Gaze, WH; Gosse, JA; Graham, DW; Graham, PA; Guastella, G; Guerrero, S; Gul, M; Guo, B; Guo, X; Gupta, VK; Hafidi, M; Halland, A; Han, W; Hardisty, M; Hasegawa, K; Hess, ST; Heydari, R; Hillary, LS; Holm, R; Huang, L; Jaleh, B; Jayasundara, JASB; Ji, X; Jiang, L; Jones, DL; Kac, G; Kebaili, I; Kelley, JB; Kelum, SHP; Kennedy, LJ; Khan, NA; Khazalpour, S; Khuntia, HK; Kinney, MS; Kommedal, Ø; Koomhin, P; Krawczyk, N; Kæstel, T; Lakmal, MAC; Li, H; Li, K; Li, R; Li, S; Li, W; Li, X; Li, Y; Liang, L; Lin, Y; Lippo, E; Liu, B; Liu, F; Liu, J; Liu, X; Liu, Y; Lodha, D; Loose, DS; López-Meza, P; Lu, F; Lu, KH; Lu, Y; Luo, Y; Ma, B; Malham, SK; Masood, A; Matan, N; McCormick, SD; McDonald, JE; McKenzie, LJ; Melendez, BD; Mikaeili, F; Mir, IR; Mirjalili, MH; Moreno, KP; Moura, IB; Müller, S; Nagata, JM; Nasri, A; Nasrollahzadeh, M; Navarro-Jiménez, E; Nie, E; Nielsen, CU; Nielsen, S; Nøhr, MK; Obeng, B; Odetayo, AA; Ortiz-Barrios, M; Ozgen, C; Pan, X; Parisi, ML; Paskavitz, AL; Patel, AK; Pedersen, M; Pontarollo, N; Potts, CM; Price, C; Pu, Y; Quénéa, K; Rahimi Khonakdari, M; Rather, BA; Raut, P; Regish, AM; Reible, DD; Rezadoost, H; Rizzati, M; Roviello, GN; Roviello, V; Rumpel, C; Sang, J; Sangroula, S; Saraiva, MDCP; Sarker, A; Sayyed, MI; Segoshi, A; Sehar, Z; Shao, X; Shaw, D; Shaw, L; Shekhawat, NS; Shim, JK; Shokouhimehr, M; Short, A; Soliman, PT; Songsamoe, S; Springer-Miller, RH; Stenstad, T; Strobl, E; Sun, R; Syme, H; Thai, L; Tian, G; Tofighi, B; Tonguc, B; Tuyiringire, D; Ulaganathan, N; Ulvestad, E; Varacca, A; Vergalli, S; Verma, DK; Villmones, HC; Wang, D; Wang, H; Wang, J; Wang, L; Wang, M; Wang, S; Wang, Y; Wang, Z; Weedon-Fekjær, H; Weller, SR; West, BE; Wilcox, MH; Wu, W; Wufuer, R; Xia, S; Xiang, H; Xu, H; Yan, L; Yang, RK; Yang, Y; Yates, MS; Ye, Q; Yin, H; Yin, Y; Yuan, Y; Yucesan, M; Yue, W; Zeng, W; Zhang, C; Zhang, D; Zhang, H; Zhang, L; Zhang, Q; Zhang, Y; Zhou, B; Zhou, Y; Zhu, Y; Zhu, Z | 1 |
| Costa-Lotufo, LV; Dartora, VFMC; de Matos, JKR; de Oliveira, EA; Giacone, DV; Lopes, LB; Maria-Engler, SS; Miranda, DAG; Passos, JS; Silveira, ER | 1 |
| Chen, L; Gao, Z; Guan, Y; Huang, W; Jin, M; Liu, X; Qi, L; Xin, X; Zhang, Y | 1 |
| He, J; Huang, X; Sun, K; Teng, W; Tian, J; Yang, J; Zhan, X; Zhou, C; Zhou, L | 1 |
| Chuan, D; Fan, R; Guo, G; Han, B; Liang, X; Mu, M; Tong, A; Yu, W; Zhao, N; Zhao, S | 1 |
| Gong, C; Gong, S; He, T; Li, L; Li, X; Liang, X; Wu, Q; Zhang, M; Zhu, S | 1 |
| Alipanah, H; Farjam, M; Osanloo, M; Roozitalab, G; Zarenezhad, E | 1 |
| Azadikhah, F; Hadizadeh, M; Karimi, AR; Yousefi, GH | 1 |
| Hou, Y; Liu, X; Xu, Y; Yin, L; Zhao, S | 1 |
| Colturato-Kido, C; Ferraz, LS; Paredes-Gamero, EJ; Pelegrino, MT; Rodrigues, T; Seabra, AB; Watashi, CM; Weller, RB | 1 |
| Nawaz, A; Wong, TW | 1 |
| Chen, X; Liu, C; Peng, D; Sun, L; Tang, S; Xie, H; Yu, J; Zhang, X; Zhou, J | 1 |
| Guerra, B; Hochscherf, J; Issinger, OG; Olsen, LF; Stie, MB; Thoke, HS | 1 |
| Cho, HJ; Koo, JS; Lee, SY; Yang, M | 1 |
| Barone, A; Cabral, C; Mare, R; Mendes, M; Paolino, D; Vitorino, C | 1 |
| Aluicio-Sarduy, E; Ferreira, DM; Saga, YY; Tedesco, AC | 1 |
| Andoh, T; Arita, Y; Fujii, F; Fujimoto, T; Fukasawa, T; Fukumori, Y; Ichikawa, H; Sakurai, Y; Shinto, H; Suzuki, M; Uneme, T | 1 |
| Adhami, VM; Bharali, DJ; Chamcheu, JC; Khan, MI; Khan, N; Mousa, SA; Mukhtar, H; Nihal, M; Shabana, S; Siddiqui, IA | 1 |
| Auger, FA; Bolduc, S; Bouhout, S; Chabaud, S; Gibot, L; Moulin, VJ | 1 |
| Jie, L; Juqun, X; Li, Q; Mingchun, J; Weijuan, G; Weiming, X; Xingyuan, P; Yan, C; Yanbing, D; Yongqi, W | 1 |
| Jacques, AV; Lemos-Senna, E; Loch-Neckel, G; Mazzarino, L; Moccelin, B; Santos-Bubniak, L; Santos-Silva, MC | 1 |
| Bonatto, CC; Joanitti, GA; Silva, LP | 1 |
| Duan, S; He, J; Huang, X; Huang, Y; Lai, C; Lu, X; Meng, J; Qian, Z; Su, J; Yu, X; Zhang, Z; Zhao, Y; Zhou, N; Zhou, S | 1 |
| Bani, D; Biagioni, A; Bianchini, F; Calorini, L; Chillà, A; Del Rosso, M; Fibbi, G; Laurenzana, A; Margheri, F; Margheri, G; Olmi, R; Severi, M; Torre, E; Traversi, R; Trigari, S; Zoppi, A | 1 |
| Bumgardner, JD; Gaber, MW; Haggard, WO; Kim, S; Liu, Y; Yang, Y | 1 |
| Huang, J; Wang, R; Wei, M; Zeng, X | 1 |
| Banerjee, P; Shen, J; Wu, W; Zhou, S | 1 |
| Domnanich, P; Peña, DB; Preininger, C | 1 |
| Bar-Eli, M; Han, HD; Lee, SJ; Lopez-Berestein, G; Mora, EM; Nishimura, M; Roh, JW; Sood, AK; Stone, RL | 1 |
| Gorzelanny, C; Moerschbacher, BM; Pöppelmann, B; Schneider, SW; Strozyk, E | 1 |
| Ben, SB; Liu, SS; Zhao, HL | 1 |
| Chan Kwon, I; Chi, DY; Choi, K; Kang, E; Kim, IS; Kim, JH; Kim, K; Kim, YS; Lee, S; Nam, HY; Park, JH; Park, K; Park, RW | 1 |
2 review(s) available for chitosan and Malignant Melanoma
| Article | Year |
|---|---|
Topics: Acyclic Monoterpenes; Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Air Pollutants; Air Pollutants, Occupational; Amino Acid Transport Systems; Analgesics, Opioid; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Arthrobacter; Bacteria; Bacteriological Techniques; Benzaldehydes; Biodegradation, Environmental; Biofilms; Biological Transport; Biomarkers; Biomass; Bioreactors; Body Composition; Body Mass Index; Brassica; Brazil; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Caco-2 Cells; Cadmium; Calcium; Calcium Carbonate; Calcium Channels; Catalysis; Cell Degranulation; Cell Line; Cell Membrane; Chitosan; Chromatography, High Pressure Liquid; Chromium; Cobalt; Cohort Studies; Colony Count, Microbial; Composting; Copper; COVID-19; Cross-Sectional Studies; Cytoplasm; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Diarrhea; Diethylhexyl Phthalate; Dose-Response Relationship, Drug; Drug Implants; Drug Stability; Drug Synergism; Electroplating; Endometrial Neoplasms; Endometrium; Environmental Monitoring; Environmental Restoration and Remediation; Estradiol; Estrogens; Feces; Female; Food Microbiology; Food Preservation; Fruit and Vegetable Juices; Gasotransmitters; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gene Expression Regulation, Developmental; Genetic Predisposition to Disease; Glutathione; Gold; Graphite; Growth Hormone; Harm Reduction; Hot Temperature; Humans; Hydrocortisone; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydrogen-Ion Concentration; Ileum; Imidazoles; Injections, Intraperitoneal; Insecticides; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 5; Insulin-Like Growth Factor I; Intestinal Absorption; Light; Lignin; Liver; Magnetics; Male; Manganese; Mast Cells; Melanoma; Membrane Potentials; Metals; Methadone; Microbial Viability; Microplastics; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Middle Aged; Mitochondrial Swelling; Molecular Dynamics Simulation; Monophenol Monooxygenase; Morocco; Naloxone; Naltrexone; Nanocomposites; Nanomedicine; Nanoparticles; Narcotic Antagonists; Neonicotinoids; Nitric Oxide; Nitro Compounds; Nitrogen; Nitrogen Compounds; Obesity; Obesity, Abdominal; Occupational Exposure; Ontario; Opiate Substitution Treatment; Opioid-Related Disorders; Oryza; Overweight; Oxidative Stress; Oxides; Oxygen; Perception; Photoelectron Spectroscopy; Plants; Plastics; Point Mutation; Polychlorinated Biphenyls; Polycyclic Aromatic Hydrocarbons; Potassium; Premenopause; Prodrugs; Prospective Studies; Protons; Pyrolysis; Qualitative Research; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resins, Synthetic; Rhodamines; Risk Factors; ROC Curve; Salmo salar; SARS-CoV-2; Seawater; Severity of Illness Index; Sewage; Social Media; Soil; Soil Microbiology; Soil Pollutants; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Staining and Labeling; Stainless Steel; Steel; Stress, Physiological; Substance Abuse Treatment Centers; Symporters; T-Lymphocytes; Toluene; Triclosan; Ultraviolet Rays; Waist Circumference; Waste Disposal, Fluid; Wastewater; Water Purification; Welding; X-Ray Diffraction; Young Adult | 2020 |
Chitosan nanoparticles for melanoma cancer treatment by Photodynamic Therapy and electrochemotherapy using aminolevulinic acid derivatives.
Topics: Aminolevulinic Acid; Chitosan; Drug Delivery Systems; Electrochemotherapy; Humans; Melanoma; Nanoparticles; Photochemotherapy | 2013 |
47 other study(ies) available for chitosan and Malignant Melanoma
| Article | Year |
|---|---|
Controlled release of 5-fluorouracil to melanoma cells using a hydrogel/micelle composites based on deoxycholic acid and carboxymethyl chitosan.
Topics: Chitosan; Delayed-Action Preparations; Deoxycholic Acid; Drug Carriers; Drug Delivery Systems; Fluorouracil; Humans; Hydrogels; Melanoma; Micelles; Skin Neoplasms; Spectroscopy, Fourier Transform Infrared | 2022 |
Hybrid Theranostic Cubosomes for Efficient NIR-Induced Photodynamic Therapy.
Topics: Chitosan; Folic Acid; Humans; Melanoma; Nanoparticles; Photochemotherapy; Precision Medicine | 2022 |
The possibility of angiogenesis inhibition in cutaneous melanoma by bevacizumab-loaded lipid-chitosan nanoparticles.
Topics: Angiogenesis Inhibitors; Bevacizumab; Chitosan; Humans; Lipids; Melanoma; Melanoma, Cutaneous Malignant; Nanoparticles; Skin Neoplasms | 2023 |
Tumor immunotherapy boosted by R837 nanocrystals through combining chemotherapy and mild hyperthermia.
Topics: Cell Line, Tumor; Chitosan; Humans; Hydrogels; Hyperthermia, Induced; Imiquimod; Immunotherapy; Melanoma; Nanoparticles | 2022 |
Preparation of Cod Skin Collagen Peptides/Chitosan-Based Temperature-Sensitive Gel and Its Anti-Photoaging Effect in Skin.
Topics: Animals; Chitosan; Collagen; Interleukin-10; Interleukin-6; Matrix Metalloproteinase 3; Melanoma; Mice; Mice, Nude; NF-kappa B; Peptides; Quality of Life; Reactive Oxygen Species; Skin Aging; Skin Diseases; Skin Neoplasms; Temperature; Ultraviolet Rays | 2023 |
Metastatic Melanoma: A Preclinical Model Standardization and Development of a Chitosan-Coated Nanoemulsion Containing Temozolomide to Treat Brain Metastasis.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Chitosan; Dacarbazine; Humans; Melanoma; Mice; Temozolomide | 2023 |
Determination of Common microRNA Biomarker Candidates in Stage IV Melanoma Patients and a Human Melanoma Cell Line: A Potential Anti-Melanoma Agent Screening Model.
Topics: Animals; Biomarkers; Cell Line; Chitosan; Humans; Humic Substances; Melanoma; Mice; MicroRNAs; Neoplasm Recurrence, Local; Pilot Projects; Skin Neoplasms | 2023 |
Preparation of chitosan nanoparticles for simultaneous drug delivery of dacarbazine and enoxaparin in melanoma.
Topics: Chitosan; Dacarbazine; Drug Delivery Systems; Enoxaparin; Humans; Melanoma; Nanoparticles | 2023 |
Fluorocarbon Modified Chitosan to Enable Transdermal Immunotherapy for Melanoma Treatment.
Topics: Chitosan; Fluorocarbons; Humans; Immunotherapy; Melanoma; Tumor Microenvironment | 2023 |
PMN-incorporated multifunctional chitosan hydrogel for postoperative synergistic photothermal melanoma therapy and skin regeneration.
Topics: Anti-Bacterial Agents; Chitosan; Gold; Humans; Hydrogels; Melanoma; Metal Nanoparticles; Nanogels; Neoplasm Recurrence, Local; Polyphenols; Reactive Oxygen Species | 2023 |
Comparison of chitosan nanoparticles containing Lippia citriodora essential oil and citral on the induction of apoptosis in A375 melanoma cells.
Topics: Apoptosis; Chitosan; Humans; Lippia; Melanoma; Nanoparticles; Oils, Volatile | 2023 |
Discovering pH triggered charge rebound surface modulated topical nanotherapy against aggressive skin papilloma.
Topics: Animals; Apoptosis; Biocompatible Materials; Cell Line; Chitosan; Down-Regulation; Drug Carriers; Drug Liberation; Gels; Hemolysis; Humans; Hydrogen-Ion Concentration; Male; Melanoma; Mice; Nanostructures; Organotechnetium Compounds; Particle Size; Skin Neoplasms; Temozolomide | 2020 |
Efficient inhibition of uveal melanoma via ternary siRNA complexes.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Chitosan; Drug Carriers; Gene Expression Regulation, Neoplastic; Humans; Hyaluronic Acid; Hypoxia-Inducible Factor 1, alpha Subunit; Melanoma; Nanoparticles; Neoplasm Invasiveness; Particle Size; RNA, Small Interfering; Uveal Neoplasms; Vascular Endothelial Growth Factor A | 2020 |
Construction of a core-shell microneedle system to achieve targeted co-delivery of checkpoint inhibitors for melanoma immunotherapy.
Topics: Administration, Cutaneous; Animals; Antineoplastic Agents; Chitosan; Crystallization; Female; Immune Checkpoint Inhibitors; Immunotherapy; Melanoma; Mice, Inbred C57BL; Needles; Polymers; Rats, Sprague-Dawley | 2020 |
Chitosan-Based Nanoparticles for Intracellular Delivery of ISAV Fusion Protein cDNA into Melanoma Cells: A Path to Develop Oncolytic Anticancer Therapies.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; DNA, Complementary; Giant Cells; Humans; Isavirus; Lymphocytes; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nanomedicine; Nanoparticles; Oncolytic Virotherapy; Orthomyxoviridae Infections; Recombinant Fusion Proteins; Skin Neoplasms; Surface Properties; Transfection | 2020 |
Development of chitosan, gelatin and liposome film and analysis of its biocompatibility in vitro.
Topics: Biocompatible Materials; Calorimetry, Differential Scanning; Cell Line, Tumor; Cell Survival; Cells, Cultured; Chitosan; Gelatin; Humans; Immunophenotyping; Liposomes; Melanoma; Mesenchymal Stem Cells | 2020 |
Folate-induced nanostructural changes of oligochitosan nanoparticles and their fate of cellular internalization by melanoma.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chitin; Chitosan; Drug Carriers; Fluorouracil; Folic Acid; Humans; Melanoma; Melanoma, Cutaneous Malignant; Nanoparticles; Oligosaccharides; Skin Neoplasms | 2020 |
Effect of nanoemulsion modification with chitosan and sodium alginate on the topical delivery and efficacy of the cytotoxic agent piplartine in 2D and 3D skin cancer models.
Topics: Alginates; Cell Proliferation; Chitosan; Cytotoxins; Emulsions; Humans; Melanocytes; Melanoma; Nanoparticles; Piperidones; Skin Neoplasms | 2020 |
Enhancing anti-melanoma outcomes in mice using novel chitooligosaccharide nanoparticles loaded with therapeutic survivin-targeted siRNA.
Topics: Animals; Cell Line, Tumor; Chitin; Chitosan; Melanoma; Mice; Nanoparticles; Oligosaccharides; RNA, Small Interfering; Survivin | 2021 |
CD47-mediated DTIC-loaded chitosan oligosaccharide-grafted nGO for synergistic chemo-photothermal therapy against malignant melanoma.
Topics: CD47 Antigen; Cell Line, Tumor; Chitosan; Dacarbazine; Doxorubicin; Humans; Melanoma; Nanoparticles; Oligosaccharides; Phototherapy; Photothermal Therapy; Skin Neoplasms | 2021 |
Chitosan coated pH-responsive metal-polyphenol delivery platform for melanoma chemotherapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Liberation; Hydrogen-Ion Concentration; Ki-67 Antigen; Melanoma; Metal Nanoparticles; Mice; Particle Size; Platelet Endothelial Cell Adhesion Molecule-1; Polyphenols; Taxoids; Tumor Microenvironment | 2021 |
A spontaneous multifunctional hydrogel vaccine amplifies the innate immune response to launch a powerful antitumor adaptive immune response.
Topics: Adaptive Immunity; Animals; Cancer Vaccines; Cell Line, Tumor; Chitosan; Dendritic Cells; Female; Hydrogels; Immunity, Innate; Immunotherapy; Inflammation; Macrophages; Mannans; Melanoma; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Ovalbumin; Rheology; Schiff Bases; T-Lymphocytes; Tumor Microenvironment | 2021 |
Chitosan nanoparticles containing limonene and limonene-rich essential oils: potential phytotherapy agents for the treatment of melanoma and breast cancers.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Chitosan; Citrus; Drug Delivery Systems; Female; Humans; Limonene; Melanoma; Nanoparticles; Phytotherapy | 2021 |
Dual antioxidant-photosensitizing hydrogel system: Cross-linking of chitosan with tannic acid for enhanced photodynamic efficacy.
Topics: Antioxidants; Cell Line, Tumor; Cell Survival; Chitosan; Cross-Linking Reagents; Dental Pulp; Humans; Hydrogels; Melanoma; Oxidative Stress; Photochemotherapy; Photosensitizing Agents; Polyphenols; Reactive Oxygen Species; Stem Cells; Tannins | 2021 |
Chitosan-Poly(Acrylic Acid) Nanoparticles Loaded with R848 and MnCl
Topics: Acrylic Resins; Animals; CD8-Positive T-Lymphocytes; Chitosan; Dendritic Cells; Macrophages; Melanoma; Mice; Nanoparticles; Tumor Microenvironment | 2021 |
Antitumor Potential of S-Nitrosothiol-Containing Polymeric Nanoparticles against Melanoma.
Topics: Animals; Apoptosis; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Screening Assays, Antitumor; Melanocytes; Melanoma; Mice; Mitochondria; Nanoparticles; Oxidative Stress; S-Nitrosothiols; Skin Neoplasms; Superoxides | 2018 |
Chitosan-Carboxymethyl-5-Fluorouracil-Folate Conjugate Particles: Microwave Modulated Uptake by Skin and Melanoma Cells.
Topics: Administration, Cutaneous; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Fluorouracil; Folic Acid; Humans; Melanoma; Membrane Microdomains; Microwaves; Nanoparticles; Skin; Skin Absorption; Skin Neoplasms | 2018 |
A targeted therapy for melanoma by graphene oxide composite with microRNA carrier.
Topics: Anticholesteremic Agents; Cell Proliferation; Chitosan; DNA-Binding Proteins; Drug Carriers; Drug Screening Assays, Antitumor; Graphite; Humans; Melanoma; MicroRNAs; Oxides; Structure-Activity Relationship; Tumor Cells, Cultured | 2018 |
Delivery of proteins encapsulated in chitosan-tripolyphosphate nanoparticles to human skin melanoma cells.
Topics: Animals; Cattle; Chitosan; Drug Delivery Systems; Humans; Hydrogen-Ion Concentration; Melanoma; Nanoparticles; Particle Size; Serum Albumin, Bovine; Skin Neoplasms; Surface Properties; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2019 |
Application of temporary agglomeration of chitosan-coated nanoparticles for the treatment of lung metastasis of melanoma.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Drug Carriers; Drug Liberation; Humans; Lung Neoplasms; Melanoma; Mice; Nanoparticles; Neoplasm Metastasis; Optical Imaging; Particle Size; Phloretin; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties | 2019 |
Hybrid Nanostructured Films for Topical Administration of Simvastatin as Coadjuvant Treatment of Melanoma.
Topics: Adhesives; Administration, Topical; Animals; Cell Line; Chitosan; Chlorocebus aethiops; COS Cells; Drug Carriers; Drug Liberation; Humans; Lipids; Melanoma; Melanoma, Cutaneous Malignant; Nanoparticles; Nanostructures; Particle Size; Permeability; Simvastatin; Skin; Skin Absorption; Skin Neoplasms | 2019 |
Gadolinium-loaded chitosan nanoparticles for neutron-capture therapy: Influence of micrometric properties of the nanoparticles on tumor-killing effect.
Topics: Animals; Boron Neutron Capture Therapy; Cell Line, Tumor; Chitosan; Gadolinium; Injections, Intralesional; Male; Melanoma; Mice; Mice, Inbred C57BL; Nanocapsules; Particle Size; Radiotherapy Dosage; Treatment Outcome | 2014 |
Excellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo.
Topics: Animals; Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Chitosan; Humans; Male; Melanoma; Mice; Mice, Nude; Nanoparticles; Nanotechnology; Xenograft Model Antitumor Assays | 2014 |
Anticancer properties of chitosan on human melanoma are cell line dependent.
Topics: Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Chitosan; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Reactive Oxygen Species; Skin Neoplasms | 2015 |
Delivery of human NKG2D-IL-15 fusion gene by chitosan nanoparticles to enhance antitumor immunity.
Topics: Animals; Cancer Vaccines; Cell Line; Cell Line, Tumor; Chitosan; Humans; Immunity; Interleukin-15; Melanoma; Mice, Inbred C57BL; Nanoparticles; NK Cell Lectin-Like Receptor Subfamily K; Plasmids; Transfection; Vaccines, DNA | 2015 |
Orally Administered Chitosan-Coated Polycaprolactone Nanoparticles Containing Curcumin Attenuate Metastatic Melanoma in the Lungs.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Movement; Chitosan; Curcumin; Female; Intestinal Absorption; Matrix Metalloproteinase 2; Melanoma; Melanoma, Cutaneous Malignant; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Neoplasm Metastasis; Polyesters; Skin Neoplasms | 2015 |
In vitro cytotoxic activity of chitosan-bullfrog oil microemulsion against melanoma cells.
Topics: Animals; Antineoplastic Agents; Biological Products; Cell Line, Tumor; Cell Survival; Chitosan; Emulsions; Melanoma; Oils; Particle Size; Rana catesbeiana | 2015 |
Folate-modified Chitosan Nanoparticles Containing the IP-10 Gene Enhance Melanoma-specific Cytotoxic CD8(+)CD28(+) T Lymphocyte Responses.
Topics: Adoptive Transfer; Animals; CD28 Antigens; CD8-Positive T-Lymphocytes; Chemokine CXCL10; Chitosan; Cytotoxicity, Immunologic; Disease Models, Animal; Drug Carriers; Folic Acid; Melanoma; Mice; Nanoparticles; Survival Analysis; Treatment Outcome | 2016 |
Tumor-tropic endothelial colony forming cells (ECFCs) loaded with near-infrared sensitive Au nanoparticles: A "cellular stove" approach to the photoablation of melanoma.
Topics: Animals; Cell Movement; Cell Survival; Chitosan; Colloids; Endothelial Cells; Female; Gold; Humans; Ions; Light; Melanoma; Metal Nanoparticles; Mice; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Physiologic; Photochemistry; Receptors, CXCR4; Skin Neoplasms; Tumor Microenvironment | 2016 |
Development of chitosan-ellagic acid films as a local drug delivery system to induce apoptotic death of human melanoma cells.
Topics: Apoptosis; Cell Adhesion; Cell Line; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Ellagic Acid; Fibroblasts; Humans; Infant, Newborn; Melanoma; Microscopy, Electron, Scanning; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2009 |
The synergy of 6-O-sulfation and N- or 3-O-sulfation of chitosan is required for efficient inhibition of P-selectin-mediated human melanoma A375 cell adhesion.
Topics: Cell Adhesion; Cell Line, Tumor; Chitosan; Drug Synergism; Humans; Melanoma; Oxygen; P-Selectin; Sulfates | 2010 |
Chitosan-based responsive hybrid nanogels for integration of optical pH-sensing, tumor cell imaging and controlled drug delivery.
Topics: Animals; Biosensing Techniques; Cadmium Compounds; Cell Line, Tumor; Cell Survival; Chitosan; Delayed-Action Preparations; Hydrogels; Hydrogen-Ion Concentration; Melanoma; Mice; Microscopy; Polymethacrylic Acids; Quantum Dots; Selenium Compounds | 2010 |
Xanthan/chitosan gold chip for metal enhanced protein biomarker detection.
Topics: Biomarkers, Tumor; Biosensing Techniques; Cell Line, Tumor; Chitosan; Equipment Design; Equipment Failure Analysis; Gold; Humans; Immunoassay; Melanoma; Neoplasm Proteins; Polysaccharides, Bacterial; Protein Array Analysis; Spectrometry, Fluorescence | 2011 |
Chitosan hydrogel for localized gene silencing.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Female; Gene Silencing; Humans; Hydrogels; Melanoma; Mice; Mice, Nude; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2011 |
Specific interaction between chitosan and matrix metalloprotease 2 decreases the invasive activity of human melanoma cells.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chitosan; Chromatography, Affinity; Dogs; Gelatin; Humans; Matrix Metalloproteinase 2; Melanoma; Microscopy, Atomic Force; Models, Biological; Neoplasm Invasiveness; Skin Neoplasms | 2007 |
[Construction of apoptin gene delivery system and its effect on apoptosis of A375 cells].
Topics: Apoptosis; Capsid Proteins; Cell Line, Tumor; Chitosan; Gene Transfer Techniques; Humans; Melanoma; Nanoparticles; Polymerase Chain Reaction | 2008 |
Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy.
Topics: Angiogenesis Inhibitors; Animals; Chitosan; Delayed-Action Preparations; Drug Carriers; Glycols; Male; Materials Testing; Melanoma; Mice; Mice, Nude; Nanoparticles; Neovascularization, Pathologic; Oligopeptides; Treatment Outcome | 2008 |